Because the culture retains primarily lymphocytes and monocytes, researchers can examine responses from more than one immune-cell population in the same experimental system. This diversity makes it possible to study cell signaling and immune-cell interactions alongside individual outcomes such as proliferation, cytokine secretion, and cytotoxicity, providing a broader view of human immune-cell behavior.
The selected stimulus helps define the response under investigation. Mitogens can activate cellular responses broadly, whereas antigens, cytokines, or other stimuli provide different experimental inputs. By choosing among these conditions, researchers can focus on responses relevant to activation, signaling, cytokine production, proliferation, cytotoxicity, or interactions between immune-cell populations.
PBMC culture supports several complementary readouts rather than a single endpoint. Researchers may assess whether cells proliferate, which cytokines they secrete, how signaling changes, whether cytotoxic activity occurs, and how immune-cell populations interact. Together, these measurements help characterize both the behavior of individual cellular responses and the coordinated activity of the mixed immune-cell system.
A typical workflow begins with peripheral blood, followed by isolation of peripheral blood mononuclear cells through density-gradient centrifugation. The recovered cells are then maintained in suitable culture medium under controlled laboratory conditions. Researchers may subsequently add a mitogen, antigen, cytokine, or another stimulus when the experiment requires activation of a defined immune response.
Researchers use this ex vivo model when they need to investigate human immune-cell behavior in a controlled laboratory setting while retaining diverse immune-cell populations. Supported applications include studies of infection, inflammation, immunotherapy, vaccine responses, and drug effects. The approach can therefore connect cellular measurements with biologically relevant immune processes.
Researchers can expose cultured cells to relevant stimuli or treatment conditions and then examine outcomes such as proliferation, cytokine secretion, signaling, cytotoxicity, and immune-cell interactions. These measurements provide experimental evidence about how a treatment or immune challenge affects human immune cells, making the culture useful for comparing cellular responses across infection, vaccination, immunotherapy, or drug-related studies.